Patent ID: 11945786
Assignee: SIGILON THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A compound of Formula (II-k):, , or a salt thereof, wherein:
Z1 is heterocyclyl or aryl, wherein each heterocyclyl or aryl is optionally substituted with 1-5 R5;
each of R2a, R2b, R2c, and R2d is independently hydrogen or alkyl,
or R2a and R2b or R2c and R2d are taken together to form an oxo group;
RC is hydrogen or alkyl;
RD is hydrogen, alkyl, or alkenyl, wherein each of alkyl and alkenyl is optionally substituted with 1-6 R6;
R6 is alkyl, alkenyl, halogen or oxo;
each of R3 and R5 is independently alkyl, alkenyl, alkynyl, heteroalkyl, halogen, cyano, azido, oxo, —ORA1, —C(O)ORA1, —C(O)RB1, —OC(O)RB1, —N(RC1)(RD1), —N(RC1)C(O)RB1, —C(O)N(RC1)(RD1), SRE1, cycloalkyl, heterocyclyl, aryl, or heteroaryl;
each RA1, RB1, RC1, RD1, and RE1 is independently hydrogen, alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, wherein each of alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl is optionally substituted with 1-6 R7;
each R7 is independently alkyl, alkenyl, alkynyl, heteroalkyl, halogen, cyano, oxo, hydroxyl, cycloalkyl, or heterocyclyl;
each of m and n is 1;
p is 0, 1, 2, 3, or 4;
q is an integer from 1 to 25,
wherein the triazolyl ring is, provided the compound is not,